Diebold Nixdorf, Incorporated (NYSE:DBD – Get Free Report) EVP Thomas Timko acquired 672 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were bought at an average cost of $74.36 per share, for a total transaction of $49,969.92. Following the acquisition, the executive vice president owned 75,480 shares of the company’s stock, valued at $5,612,692.80. This represents a 0.90% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Diebold Nixdorf Stock Up 2.8%
DBD stock opened at $74.44 on Friday. The company has a market cap of $2.58 billion, a P/E ratio of 25.23 and a beta of 1.16. Diebold Nixdorf, Incorporated has a 52 week low of $46.47 and a 52 week high of $89.05. The company’s 50-day moving average price is $77.92 and its 200 day moving average price is $72.51. The company has a current ratio of 1.28, a quick ratio of 0.89 and a debt-to-equity ratio of 0.92.
Diebold Nixdorf (NYSE:DBD – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The technology company reported $0.60 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The company had revenue of $888.20 million for the quarter, compared to analysts’ expectations of $846.23 million. Diebold Nixdorf had a return on equity of 18.82% and a net margin of 2.80%.Diebold Nixdorf has set its FY 2026 guidance at 5.250-5.75 EPS. On average, research analysts expect that Diebold Nixdorf, Incorporated will post 5.5 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Hedge Funds Weigh In On Diebold Nixdorf
A number of institutional investors have recently modified their holdings of the company. Bank of America Corp DE raised its position in shares of Diebold Nixdorf by 15.8% in the first quarter. Bank of America Corp DE now owns 122,840 shares of the technology company’s stock valued at $9,267,000 after buying an additional 16,751 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of Diebold Nixdorf by 1,815.0% in the first quarter. Janus Henderson Group PLC now owns 126,387 shares of the technology company’s stock valued at $9,535,000 after buying an additional 119,787 shares during the last quarter. California State Teachers Retirement System raised its position in shares of Diebold Nixdorf by 40.6% in the first quarter. California State Teachers Retirement System now owns 20,587 shares of the technology company’s stock valued at $1,553,000 after buying an additional 5,944 shares during the last quarter. Quantinno Capital Management LP raised its position in shares of Diebold Nixdorf by 28.3% in the first quarter. Quantinno Capital Management LP now owns 19,548 shares of the technology company’s stock valued at $1,475,000 after buying an additional 4,310 shares during the last quarter. Finally, Lazard Asset Management LLC raised its position in shares of Diebold Nixdorf by 17.4% in the first quarter. Lazard Asset Management LLC now owns 97,001 shares of the technology company’s stock valued at $7,318,000 after buying an additional 14,389 shares during the last quarter. Institutional investors and hedge funds own 97.04% of the company’s stock.
Diebold Nixdorf Company Profile
Diebold Nixdorf, Inc (NYSE: DBD) is a leading global provider of connected commerce solutions, specializing in automated teller machines (ATMs), point-of-sale (POS) systems and related software and services for the banking and retail industries. The company’s core offerings include hardware platforms, software applications for transaction management and advanced analytics tools that enable financial institutions and retailers to enhance customer engagement, streamline operations and improve security at the point of transaction.
Further Reading
- Five stocks we like better than Diebold Nixdorf
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Diebold Nixdorf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diebold Nixdorf and related companies with MarketBeat.com's FREE daily email newsletter.
